Dirk de Meester

Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY.

Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium.

Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands.

Eurofiber Nederland BV engages in the provision of open digital infrastructure solutions. It offers continuity, secure collaboration, cloud connectivity, agile organization, process optimization, and security solutions. The firm also offers managed dark fiber, ethernet, secure cloud connect, internet, Wavelength Division Multiplexing, WDM encrypted, and datacenter services. The company was founded by Laurens van Reijen and Armand Boogaarts in 2000 and is headquartered in Maarssen, Netherlands.

OPHTEC has more than 25 years of experience in meeting ophthalmologists' needs with unique and proprietary, high quality products. OPHTEC is a privately held innovative medical device manufacturer that provides unique and proprietary, high quality intraocular lenses, and a complete line of ophthalmic surgical devices for: Cataract surgery Refractive surgery Trauma surgery Cataract surgery: The major part of the products made by OPHTEC is implantable artificial lenses meant for cataract. These lenses replace the natural, opaque lens. Refractive surgery: ARTISAN and ARTIFLEX lenses are used for refractive surgery to correct myopia, hyperopia and astigmatism. They are unique patented products made by OPHTEC only. Trauma surgery: OPHTEC's iris reconstruction implants are used in cases of iris defects caused by accidents (trauma) or congenital reasons. With the aid of colored materials the missing parts of the iris are replaced in order to ensure that the right amount of light enters the eye so that the patient is no longer hindered by excessive bright light. OPHTEC distributes its products worldwide through a network of knowledgeable distributors.

Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink.

ArboNed NV provides professional services which focuses on the long-term employability of workers. It offers customer care services to the enterprises, foundations and governments agencies. The firm provides employment in the welfare, health and safety sectors. The company was founded in 1993 and is headquartered in Utrecht, the Netherlands.

ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands.

Kinesis Pharma BV provides drug development consulting services. It offers non-clinical, clinical, regulatory, and project management services for biopharmaceutical companies. The firm specializes in providing product development and regulatory consulting services to developers and manufacturers of biologic drugs such as therapeutic proteins and vaccines, prophylaxic vaccines, and therapeutic medicinal products such as cell therapy and gene therapy. The company was founded in 1997 and is headquartered in Breda, the Netherlands.

OOK Capital Partners BV is an independent private equity firm with its headquarters in Naarden, the Netherlands. It was founded in 2013.

Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands.

Diceros Therapeutics Inc provides biotechnology healthcare services.